Chromosome-free bacterial cells are safe and programmable platforms for synthetic biology
Year: 2020
Type: article
Abstract: The removal of the native chromosomes of these bacteria was achieved by double-stranded breaks made by heterologous I-CeuI endonuclease and the degradation activity of endogenous nucleases. We have shown that the cellular machinery remained functional in these chromosome-free SimCells and was able to process various genetic circuits. This includes the glycolysis pathway (composed of 10 genes) and inducible genetic circuits. It was found that the glycolysis pathway significantly extended longevity of SimCells due to its ability to regenerate ATP and NADH/NADPH. The SimCells were able to continuously express synthetic genetic circuits for 10 d after chromosome removal. As a proof of principle, we demonstrated that SimCells can be used as a safe agent (as they cannot replicate) for bacterial therapy. SimCells were used to synthesize catechol (a potent anticancer drug) from salicylic acid to inhibit lung, brain, and soft-tissue cancer cells. SimCells represent a simplified synthetic biology chassis that can be programmed to manufacture and deliver products safely without interference from the host genome.
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Awards: G1934500574, Biogeochemical cycling of N-osmolytes in the surface ocean, Engineering new capacities for solar energy utilisation in bacteria, G3697531524, Liquid Fuel and bioEnergy Supply from CO2 Reduction, Engineering Fellowships for Growth: Development of SimCells as building blocks for synthetic biology, Liquid Fuel and bioEnergy Supply from CO2 Reduction
OpenAlex ID: W3009922224
